Natixis Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Sell |
21,408
-5,284
| -20% | -$79.5K | ﹤0.01% | 1540 |
|
|
2025
Q1 | $352K | Sell |
26,692
-30,474
| -53% | -$402K | ﹤0.01% | 1522 |
|
|
2024
Q4 | $903K | Buy |
57,166
+46,229
| +423% | +$730K | ﹤0.01% | 1333 |
|
|
2024
Q3 | $174K | Buy |
10,937
+735
| +7% | +$11.7K | ﹤0.01% | 1566 |
|
|
2024
Q2 | $777K | Buy |
+10,202
| New | +$777K | ﹤0.01% | 1325 |
|
|
2024
Q1 | – | Sell |
-11,575
| Closed | -$805K | – | 1571 |
|
|
2023
Q4 | $805K | Sell |
11,575
-7,987
| -41% | -$555K | ﹤0.01% | 1270 |
|
|
2023
Q3 | $1.31M | Buy |
+19,562
| New | +$1.31M | ﹤0.01% | 1107 |
|
|
2023
Q2 | – | Sell |
-26,013
| Closed | -$1.48M | – | 1510 |
|
|
2023
Q1 | $1.48M | Buy |
+26,013
| New | +$1.48M | 0.01% | 1031 |
|
|
2017
Q2 | – | Sell |
-18,327
| Closed | -$736K | – | 1053 |
|
|
2017
Q1 | $736K | Sell |
18,327
-929
| -5% | -$37.3K | 0.01% | 918 |
|
|
2016
Q4 | $872K | Sell |
19,256
-192
| -1% | -$8.7K | 0.01% | 861 |
|
|
2016
Q3 | $903K | Sell |
19,448
-4,806
| -20% | -$223K | 0.01% | 823 |
|
|
2016
Q2 | $1.24M | Sell |
24,254
-723
| -3% | -$37.1K | 0.02% | 751 |
|
|
2016
Q1 | $1.13M | Sell |
24,977
-5,663
| -18% | -$256K | 0.02% | 769 |
|
|
2015
Q4 | $1.42M | Sell |
30,640
-1,430
| -4% | -$66.2K | 0.02% | 685 |
|
|
2015
Q3 | $2.05M | Sell |
32,070
-4,038
| -11% | -$258K | 0.04% | 594 |
|
|
2015
Q2 | $2M | Buy |
36,108
+3,281
| +10% | +$181K | 0.03% | 634 |
|
|
2015
Q1 | $1.87M | Buy |
32,827
+3,882
| +13% | +$222K | 0.03% | 639 |
|
|
2014
Q4 | $1.46M | Buy |
28,945
+399
| +1% | +$20.1K | 0.03% | 697 |
|
|
2014
Q3 | $1.5M | Sell |
28,546
-69,993
| -71% | -$3.68M | 0.03% | 676 |
|
|
2014
Q2 | $4.25M | Buy |
+98,539
| New | +$4.25M | 0.06% | 483 |
|